Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.35 |
| ▸ | PRKDC | P78527 | 4/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862931 | 0.92 | ALDH1A1 (0.37) | ALOX5PRKDCPIK3CDPIK3CBKDM4E | |
| SCHEMBL19862924 | 0.92 | ALDH1A1 (0.38) | ALOX5PRKDCPIK3CDPIK3CBKDM4E | |
| SCHEMBL19862952 | 0.90 | ALDH1A1 (0.37) | ALOX5KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL18594233 | 0.90 | SIRT2 (0.31) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL19862923 | 0.89 | PRKDC (0.32) | ALOX5PRKDCPIK3CDPIK3CB | |
| SCHEMBL18594068 | 0.89 | SIRT2 (0.31) | PIK3CDKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL19862949 | 0.87 | ALDH1A1 (0.37) | ALOX5KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL19862912 | 0.86 | SIRT2 (0.31) | — | |
| SCHEMBL19862910 | 0.86 | SIRT2 (0.31) | — | |
| SCHEMBL19862927 | 0.85 | ALDH1A1 (0.39) | ALOX5KDM4EALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10230056-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2019-03-12 | — | — | US | disclosed |
| US-20180047914-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-02-15 | — | — | US | disclosed |
| US-20180047914-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10230056-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, NR2E3 | ALOX5 1089/4885PRKDC 4232/4885PIK3CD 4731/4885 |
| US-20180047914-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, NR2E3 | ALOX5 1089/4885PRKDC 4232/4885PIK3CD 4731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.